Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction
Myocardium Infarction (MI) is one of the foremost cardiovascular diseases (CVDs) causing death worldwide, and its case numbers are expected to continuously increase in the coming years. Pharmacological interventions have not been at the forefront in ameliorating MI-related morbidity and mortality. S...
| Published in: | Cells |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-09-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/10/10/2538 |
